+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Sulphonamides Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • July 2022
  • Region: Global
  • TechNavio
  • ID: 5639399
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sulphonamides market is poised to grow by $128.42 mn during 2022-2026, accelerating at a CAGR of 4.68% during the forecast period. The report on the sulphonamides market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of infectious diseases, rising urinary tract infections among individuals, and special regulatory designations.

The sulphonamides market analysis includes formulation segment and geographic landscape.

The sulphonamides market is segmented as below:


By Formulation

  • Oral
  • Topical

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • The Middle East and Africa

This study identifies the growing awareness of various diseases and their treatment as one of the prime reasons driving the sulphonamides market growth during the next few years. Also, strategic alliances and mergers and acquisitions (M&A) and increased federal and institutional funding for antibiotic research will lead to sizable demand in the market.

The report on the sulphonamides market covers the following areas:

  • Sulphonamides market sizing
  • Sulphonamides market forecast
  • Sulphonamides market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sulphonamides market vendors that include AA Pharma Inc., Abbott Laboratories, Agron Remedies Pvt. Ltd., Amneal Pharmaceuticals Inc., C. H. Boehringer Sohn AG, and Co. KG, Cadila Pharmaceuticals Ltd., Cipla Ltd., Dhanuka Agritech Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lexine Technochem Pvt. Ltd., Novartis AG, PANPHARMA S.A., Pfizer Inc., Sanofi, Smilax Laboratories Ltd., Stedman Pharmaceuticals Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd. Also, the sulphonamides market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Formulation
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Formulation
5.1 Market segments
Exhibit 24: Chart on Formulation - Market share 2021-2026 (%)
Exhibit 25: Data Table on Formulation - Market share 2021-2026 (%)
5.2 Comparison by Formulation
Exhibit 26: Chart on Comparison by Formulation
Exhibit 27: Data Table on Comparison by Formulation
5.3 Oral - Market size and forecast 2021-2026
Exhibit 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
5.4 Topical - Market size and forecast 2021-2026
Exhibit 32: Chart on Topical - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Topical - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Topical - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Formulation
Exhibit 36: Market opportunity by Formulation ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 APAC - Market size and forecast 2021-2026
Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
7.6 South America - Market size and forecast 2021-2026
Exhibit 54: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on South America - Year-over-year growth 2021-2026 (%)
7.7 Middle East and Africa - Market size and forecast 2021-2026
Exhibit 58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
7.8 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.13 Japan - Market size and forecast 2021-2026
Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.14 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 AA Pharma Inc.
Exhibit 93: AA Pharma Inc. - Overview
Exhibit 94: AA Pharma Inc. - Product / Service
Exhibit 95: AA Pharma Inc. - Key offerings
10.4 Abbott Laboratories
Exhibit 96: Abbott Laboratories - Overview
Exhibit 97: Abbott Laboratories - Business segments
Exhibit 98: Abbott Laboratories - Key offerings
Exhibit 99: Abbott Laboratories - Segment focus
10.5 F. Hoffmann La Roche Ltd.
Exhibit 100: F. Hoffmann La Roche Ltd. - Overview
Exhibit 101: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 102: F. Hoffmann La Roche Ltd. - Key news
Exhibit 103: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 104: F. Hoffmann La Roche Ltd. - Segment focus
10.6 GlaxoSmithKline Plc
Exhibit 105: GlaxoSmithKline Plc - Overview
Exhibit 106: GlaxoSmithKline Plc - Business segments
Exhibit 107: GlaxoSmithKline Plc - Key news
Exhibit 108: GlaxoSmithKline Plc - Key offerings
Exhibit 109: GlaxoSmithKline Plc - Segment focus
10.7 Lexine Technochem Pvt. Ltd.
Exhibit 110: Lexine Technochem Pvt. Ltd. - Overview
Exhibit 111: Lexine Technochem Pvt. Ltd. - Product / Service
Exhibit 112: Lexine Technochem Pvt. Ltd. - Key offerings
10.8 Novartis AG
Exhibit 113: Novartis AG - Overview
Exhibit 114: Novartis AG - Business segments
Exhibit 115: Novartis AG - Key offerings
Exhibit 116: Novartis AG - Segment focus
10.9 Pfizer Inc.
Exhibit 117: Pfizer Inc. - Overview
Exhibit 118: Pfizer Inc. - Product / Service
Exhibit 119: Pfizer Inc. - Key news
Exhibit 120: Pfizer Inc. - Key offerings
10.10 Sanofi
Exhibit 121: Sanofi - Overview
Exhibit 122: Sanofi - Business segments
Exhibit 123: Sanofi - Key news
Exhibit 124: Sanofi - Key offerings
Exhibit 125: Sanofi - Segment focus
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 126: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 127: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 128: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 130: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 Viatris Inc.
Exhibit 131: Viatris Inc. - Overview
Exhibit 132: Viatris Inc. - Business segments
Exhibit 133: Viatris Inc. - Key offerings
Exhibit 134: Viatris Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 135: Inclusions checklist
Exhibit 136: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 137: Currency conversion rates for US$
11.4 Research methodology
Exhibit 138: Research methodology
Exhibit 139: Validation techniques employed for market sizing
Exhibit 140: Information sources
11.5 List of abbreviations
Exhibit 141: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Formulation
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Formulation - Market share 2021-2026 (%)
Exhibits 25: Data Table on Formulation - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Formulation
Exhibits 27: Data Table on Comparison by Formulation
Exhibits 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Topical - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Topical - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Topical - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Formulation ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on South America - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 86: Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2021 and 2026
Exhibits 88: Overview on Criticality of inputs and Factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Vendors covered
Exhibits 92: Matrix on vendor position and classification
Exhibits 93: AA Pharma Inc. - Overview
Exhibits 94: AA Pharma Inc. - Product / Service
Exhibits 95: AA Pharma Inc. - Key offerings
Exhibits 96: Abbott Laboratories - Overview
Exhibits 97: Abbott Laboratories - Business segments
Exhibits 98: Abbott Laboratories - Key offerings
Exhibits 99: Abbott Laboratories - Segment focus
Exhibits 100: F. Hoffmann La Roche Ltd. - Overview
Exhibits 101: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 102: F. Hoffmann La Roche Ltd. - Key news
Exhibits 103: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 104: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 105: GlaxoSmithKline Plc - Overview
Exhibits 106: GlaxoSmithKline Plc - Business segments
Exhibits 107: GlaxoSmithKline Plc - Key news
Exhibits 108: GlaxoSmithKline Plc - Key offerings
Exhibits 109: GlaxoSmithKline Plc - Segment focus
Exhibits 110: Lexine Technochem Pvt. Ltd. - Overview
Exhibits 111: Lexine Technochem Pvt. Ltd. - Product / Service
Exhibits 112: Lexine Technochem Pvt. Ltd. - Key offerings
Exhibits 113: Novartis AG - Overview
Exhibits 114: Novartis AG - Business segments
Exhibits 115: Novartis AG - Key offerings
Exhibits 116: Novartis AG - Segment focus
Exhibits 117: Pfizer Inc. - Overview
Exhibits 118: Pfizer Inc. - Product / Service
Exhibits 119: Pfizer Inc. - Key news
Exhibits 120: Pfizer Inc. - Key offerings
Exhibits 121: Sanofi - Overview
Exhibits 122: Sanofi - Business segments
Exhibits 123: Sanofi - Key news
Exhibits 124: Sanofi - Key offerings
Exhibits 125: Sanofi - Segment focus
Exhibits 126: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 127: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 128: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 129: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 130: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 131: Viatris Inc. - Overview
Exhibits 132: Viatris Inc. - Business segments
Exhibits 133: Viatris Inc. - Key offerings
Exhibits 134: Viatris Inc. - Segment focus
Exhibits 135: Inclusions checklist
Exhibits 136: Exclusions checklist
Exhibits 137: Currency conversion rates for US$
Exhibits 138: Research methodology
Exhibits 139: Validation techniques employed for market sizing
Exhibits 140: Information sources
Exhibits 141: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global sulphonamides market: AA Pharma Inc., Abbott Laboratories, Agron Remedies Pvt. Ltd., Amneal Pharmaceuticals Inc., C. H. Boehringer Sohn AG, and Co. KG, Cadila Pharmaceuticals Ltd., Cipla Ltd., Dhanuka Agritech Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lexine Technochem Pvt. Ltd., Novartis AG, PANPHARMA S.A., Pfizer Inc., Sanofi, Smilax Laboratories Ltd., Stedman Pharmaceuticals Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing awareness of various diseases and their treatment.`

According to the report, one of the major drivers for this market is the rising prevalence of infectious diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AA Pharma Inc.
  • Abbott Laboratories
  • Agron Remedies Pvt. Ltd.
  • Amneal Pharmaceuticals Inc.
  • C. H. Boehringer Sohn AG and Co. KG
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • Dhanuka Agritech Ltd.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Lexine Technochem Pvt. Ltd.
  • Novartis AG
  • PANPHARMA S.A.
  • Pfizer Inc.
  • Sanofi
  • Smilax Laboratories Ltd.
  • Stedman Pharmaceuticals Pvt. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.